Comparison of plasma fetuin A levels in patients with early-onset pre-eclampsia vs late-onset pre-eclampsia

C Y Sanhal1, M Can Kavcar1, A Yucel1

  • 1Department of Perinatology, Dr. Zekai Tahir Burak Women's Health Care, Education and Research Hospital, Ankara, Turkey.

Insights

Fetuin-A (FA) levels differ in pre-eclampsia (PE). Early-onset PE shows lower FA, indicating inflammation, while late-onset PE has higher FA levels. FA is a key predictor for early-onset PE.

Area of Science:

  • Perinatology
  • Biochemistry
  • Inflammation research

Background:

  • Pre-eclampsia (PE) is a significant perinatal complication.
  • Fetuin-A (FA) is a protein involved in calcification inhibition and glucose regulation.
  • Reduced FA levels are associated with inflammation, suggesting a potential role in PE pathophysiology.

Purpose of the Study:

  • To investigate the role of inflammation in early- and late-onset PE.
  • To measure plasma Fetuin-A (FA) levels in patients with PE.
  • To assess FA as a potential biomarker for PE subtypes.

Main Methods:

  • 110 patients were included, with PE classified as early (<34 weeks) or late (≥34 weeks) onset.
  • Plasma FA levels were quantified using a sandwich enzyme-based immunoassay.
  • Statistical analyses included t-tests, Mann-Whitney U-test, logistic regression, and ROC analysis.

Main Results:

  • Early-onset PE patients had significantly lower FA levels compared to controls (17.3±3.3 ng/ml vs 21.4±3.5 ng/ml).
  • Late-onset PE patients exhibited significantly higher FA levels than controls (26.1 ng/ml vs 18.4 ng/ml).
  • FA was the most important variable related to PE, with an optimal cut-off of 19.6 ng/ml for predicting early-onset PE (AUC 0.796).

Conclusions:

  • Early-onset PE is linked to lower FA levels and inflammation.
  • Late-onset PE is associated with higher FA levels, with no clear link to inflammation.
  • FA demonstrates diagnostic potential for early-onset PE but not for late-onset PE.
Abstract

Related Concept Videos